Inventor · disambiguated record
Wei-Li Liao
Also filed as: LIAO WEI-LI
21 granted patents·10 pending applications·17 citations·filing 2013–2019
91Inventor score
Top patents by PatentIndex Score
31 records- 0186US10101334B2Multiplex MRM assay for evaluation of cancerEXPRESSION PATHOLOGY INC·Filed 2016·Granted Oct 16, 2018·2 cites·21 claims
- 0286US9261506B2SRM/MRM assay for subtyping lung histologyEXPRESSION PATHOLOGY INC·Filed 2014·Granted Feb 16, 2016·4 cites·14 claims
- 0383US10203336B2SRM/MRM assay for the tyrosine-protein kinase receptor UFO (AXL) proteinEXPRESSION PATHOLOGY INC·Filed 2015·Granted Feb 12, 2019·2 cites·19 claims
- 0483US9360487B2Multiplex MRM assay for evaluation of cancerEXPRESSION PATHOLOGY INC·Filed 2014·Granted Jun 7, 2016·3 cites·17 claims
- 0578US9309554B2SRM/MRM assay for the fatty acid synthase proteinEXPRESSION PATHOLOGY INC·Filed 2014·Granted Apr 12, 2016·2 cites·9 claims
- 0671US10202635B2SRM/MRM assay for the ephrin type-A receptor 2 proteinEXPRESSION PATHOLOGY INC·Filed 2014·Granted Feb 12, 2019·1 cites·11 claims
- 0771US9840728B2SRM assay to indicate cancer therapyEXPRESSION PATHOLOGY INC·Filed 2015·Granted Dec 12, 2017·1 cites·13 claims
- 0871US9551719B2BCL-2-like protein 11 SRM/MRM assayKRIZMAN DAVID·Filed 2013·Granted Jan 24, 2017·1 cites·12 claims
- 0971US9470696B2SRM/MRM assay for the receptor tyrosine-protein kinase erbB-4 protein (HER4)EXPRESSION PATHOLOGY INC·Filed 2014·Granted Oct 18, 2016·1 cites·17 claims
- 1070US10725051B2Multiplex MRM assay for evaluation of cancerNANTOMICS LLC·Filed 2018·Granted Jul 28, 2020·0 cites·17 claims
- 1167US10718780B2SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) proteinEXPRESSION PATHOLOGY INC·Filed 2019·Granted Jul 21, 2020·0 cites·16 claims
- 1264US9766246B2SRM/MRM assay for subtyping lung histologyEXPRESSION PATHOLOGY INC·Filed 2016·Granted Sep 19, 2017·0 cites·12 claims
- 1363US9255934B2SRM/MRM assay for the insulin receptor proteinEXPRESSION PATHOLOGY INC·Filed 2014·Granted Feb 9, 2016·0 cites·18 claims
- 1462US9442119B2MRM/SRM assay for death receptor 5 proteinEXPRESSION PATHOLOGY INC·Filed 2014·Granted Sep 13, 2016·0 cites·10 claims
- 1561US10215761B2Bcl-2-like protein 11 SRM/MRM assayEXPRESSION PATHOLOGY INC·Filed 2016·Granted Feb 26, 2019·0 cites·7 claims
- 1661US9804169B2MRM/SRM assay for death receptor 5 proteinEXPRESSION PATHOLOGY INC·Filed 2016·Granted Oct 31, 2017·0 cites·3 claims
- 1761US9470687B2SRM/MRM assay for subtyping lung histologyEXPRESSION PATHOLOGY INC·Filed 2015·Granted Oct 18, 2016·0 cites·12 claims
- 1861US2019056406A1SRM/MRM Assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) proteinNANTOMICS LLC·Filed 2018·Application pending·0 cites
- 1960US10041961B2SRM/MRM assay for the insulin receptor proteinEXPRESSION PATHOLOGY INC·Filed 2016·Granted Aug 7, 2018·0 cites·21 claims
- 2060US9804164B2SRM/MRM assay for the fatty acid synthase proteinEXPRESSION PATHOLOGY INC·Filed 2016·Granted Oct 31, 2017·0 cites·6 claims
- 2153US10620223B2SRM/MRM assay for the fibroblast growth factor receptor 2 (FGFR2) proteinEXPRESSION PATHOLOGY INC·Filed 2016·Granted Apr 14, 2020·0 cites·13 claims
- 2249US2018195107A1SRM Assay to Indicate Cancer TherapyEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 2342US2017122953A1SRM/MRM Assay for the Serine/Threonine-Protein Kinase B-RAF (BRAF)EXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 2442US2017122946A1SRM/MRM Assay for the GTPase KRas Protein (KRas)EXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 2542US2018172690A1Method for improved hepatocellular cancer diagnosisEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 2642US2020132694A1SRM/MRM Assay for the Tumor Necrosis Factor Receptor Superfamily Member 8 (CD30) ProteinEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 2741US10288616B2Quantifying met protein for cancer treatmentEXPRESSION PATHOLOGY INC·Filed 2016·Granted May 14, 2019·0 cites·11 claims
- 2840US2016313343A1SRM Assay for PD-L1EXPRESSION PATHOLOGY INC·Filed 2016·Application pending·0 cites
- 2939US2017168055A1SRM/MRM AssaysEXPRESSION PATHOLOGY INC·Filed 2016·Application pending·0 cites
- 3034US2017168057A1Srm assays to chemotherapy targetsEXPRESSION PATHOLOGY INC·Filed 2015·Application pending·0 cites
- 3133US2019293652A1Quantifying KRAS for Optimal Cancer TherapyEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wei-Li Liao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →